Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics

Ekta Khurana(Yale University), Yao Fu(Yale University), Vincenza Colonna(Wellcome Sanger Institute), Xinmeng Jasmine Mu(Yale University), Hyun Min Kang(University of Michigan), Tuuli Lappalainen(University of Geneva), Andrea Sboner(NewYork–Presbyterian Hospital), Lucas Lochovsky(Yale University), Jieming Chen(Yale University), Arif Harmanci(Yale University), Jishnu Das(Cornell University), Alexej Abyzov(Yale University), Suganthi Balasubramanian(Yale University), Kathryn Beal, Dimple Chakravarty(NewYork–Presbyterian Hospital), Daniel Challis(Baylor College of Medicine), Yuan Chen(Wellcome Sanger Institute), Declan Clarke(Yale University), Laura Clarke, Fiona Cunningham, Uday S. Evani(Baylor College of Medicine), Paul Flicek, Robert Fragoza(Cornell University), Erik Garrison(Colonial Society of Massachusetts), Richard A. Gibbs(Baylor College of Medicine), Zeynep H. Gümüş(Cornell University), Javier Herrero, Naoki Kitabayashi(NewYork–Presbyterian Hospital), Yong Kong(Yale University), Kasper Lage(Massachusetts General Hospital), Vaja Liluashvili(Cornell University), Steven M. Lipkin(Cornell University), Daniel G. MacArthur(Broad Institute), Gábor Marth(Colonial Society of Massachusetts), Donna M. Muzny(Baylor College of Medicine), Tune H. Pers(Broad Institute), Graham R. S. Ritchie, Jeffrey Rosenfeld(Rutgers, The State University of New Jersey), Cristina Sisu(Yale University), Xiaomu Wei(Cornell University), Michael Wilson(Yale University), Yali Xue(Wellcome Sanger Institute), Fuli Yu(Baylor College of Medicine), Emmanouil T. Dermitzakis(University of Geneva), Haiyuan Yu(Cornell University), Mark A. Rubin(NewYork–Presbyterian Hospital), Chris Tyler‐Smith(Wellcome Sanger Institute), Mark Gerstein(Yale University)
MPG.PuRe (Max Planck Society)
October 1, 2013
Cited by 0Open Access
Full Text

Abstract

Interpreting variants, especially noncoding ones, in the increasing number of personal genomes is challenging. We used patterns of polymorphisms in functionally annotated regions in 1092 humans to identify deleterious variants; then we experimentally validated candidates. We analyzed both coding and noncoding regions, with the former corroborating the latter. We found regions particularly sensitive to mutations ("ultrasensitive") and variants that are disruptive because of mechanistic effects on transcription-factor binding (that is, "motif-breakers"). We also found variants in regions with higher network centrality tend to be deleterious. Insertions and deletions followed a similar pattern to single-nucleotide variants, with some notable exceptions (e.g., certain deletions and enhancers). On the basis of these patterns, we developed a computational tool (FunSeq), whose application to ~90 cancer genomes reveals nearly a hundred candidate noncoding drivers.


Related Papers

No related papers found

Powered by citation graph analysis